Hai-Dong Guo
Overview
Explore the profile of Hai-Dong Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Luo Z, Huang M, Cai H, Lu P, Xu Y, et al.
Curr Pharm Des
. 2025 Jan;
PMID: 39781735
Introduction: Taohong Siwu decoction (THSWD), a traditional prescription for enhancing blood circulation and eliminating blood stasis, primarily comprises peach kernel, safflower, angelica, chuanxiong, and rehmannia. Modified Taohong Siwu decoction (MTHSWD),...
2.
Wang Y, Zhu Y, Meng W, Zheng Y, Guan X, Shao C, et al.
Eur J Pharmacol
. 2025 Jan;
989():177245.
PMID: 39753160
Dihydrotanshinone I (DHT) is an active ingredient derived from Salvia miltiorrhiza. Previous studies have demonstrated that DHT can improve cardiac function in rats with myocardial ischemia-reperfusion injury (IR). However, the...
3.
Cai H, Han X, Luo Z, Wang Q, Lu P, Mou F, et al.
Stem Cell Res Ther
. 2024 Nov;
15(1):419.
PMID: 39533348
Background: Although stem cell transplantation is a promising approach for the treatment of myocardial infarction (MI), there are still some problems faced such as the low survival rate of stem...
4.
Shao C, Meng W, Wang Y, Liu J, Ning K, Hou X, et al.
Int Immunopharmacol
. 2024 Oct;
143(Pt 2):113368.
PMID: 39418732
Neutrophil extracellular traps (NETs) are implicated in the occurrence and progression of atherosclerosis (AS), which can result in adverse cardiovascular events. We investigated the potential mechanism of action of Modified...
5.
Meng W, Zhu J, Wang Y, Shao C, Li X, Lu P, et al.
J Nanobiotechnology
. 2024 Jul;
22(1):382.
PMID: 38951872
Reperfusion therapy is critical for saving heart muscle after myocardial infarction, but the process of restoring blood flow can itself exacerbate injury to the myocardium. This phenomenon is known as...
6.
Guo H, Wu J, Wang H, Tan Y
Stem Cell Rev Rep
. 2024 Apr;
20(6):1540-1554.
PMID: 38656478
Stem cell transplantation is a promising therapeutic strategy for myocardial infarction (MI). However, engraftment, survival and differentiation of the transplanted stem cells in ischemic and inflammatory microenvironment are poor. We...
7.
Luo Z, Meng W, Li H, Wang Y, Wang Y, Zhao Y, et al.
Heliyon
. 2024 Mar;
10(4):e26700.
PMID: 38434034
Objective: This study aimed to study whether modified Taohong Siwu decoction (MTHSWD) combined with human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs) transplantation can promote cardiac function in myocardial infarction (MI)...
8.
Tian M, Yang Y, Qin W, Liu B, Mou F, Zhu J, et al.
Mol Neurobiol
. 2024 Jan;
61(2):950-952.
PMID: 38265553
No abstract available.
9.
Wang Y, Shao Y, Shao C, Guan X, Lu P, Ning K, et al.
In Vitro Cell Dev Biol Anim
. 2024 Jan;
60(1):89-97.
PMID: 38253954
Cardiovascular disease is the deadliest disease in the world. Previous studies have shown that Dihydrotanshinone I (DHT) can improve cardiac function after myocardial injury. This study aimed to observe the...
10.
Tian M, Yang Y, Qin W, Liu B, Mou F, Zhu J, et al.
Mol Neurobiol
. 2023 Sep;
61(2):935-949.
PMID: 37672149
Although the benefits of electroacupuncture (EA) for peripheral nerve injury (PNI) are well accepted in clinical practice, the underlying mechanism remains incompletely elucidated. In our study, we observed that EA...